Use of penicillin and other antibiotics and risk of multiple sclerosis: A population-based case-control study

American Journal of Epidemiology

Volumn 174, Issue 8, 2011, Pages 945-948

  Nørgaard, Mette ^a   Nielsen, Rikke Beck ^a   Jacobsen, Jacob Bonde ^a   Gradus, Jaimie L ^b,c   Stenager, Egon ^d,e,f   Koch Henriksen, Nils ^a,d   Lash, Timothy L ^a,c   Sørensen, Henrik Toft ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BOSTON UNIVERSITY   (United States)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f MS Clinic of Southern Jutland (Sønderborg Vejle Esbjerg)   (Denmark)

Author keywords

anti bacterial agents; case control studies; multiple sclerosis; penicillins; risk

Indexed keywords

COTRIMOXAZOLE; MACROLIDE; NITROFURANTOIN; PENICILLIN G; PIVMECILLINAM;

AGE STRUCTURE; ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; COMPUTER SIMULATION; DATABASE; DISEASE CONTROL; HEALTH RISK; IDENTIFICATION METHOD; INDEX METHOD; INFECTIVITY; LOGISTICS; NERVOUS SYSTEM DISORDER; POPULATION STRUCTURE; REGRESSION ANALYSIS; RISK FACTOR; SEX RATIO;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DENMARK; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; RISK FACTOR;

ADULT; ANTI-BACTERIAL AGENTS; DENMARK; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PENICILLINS; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS;

DENMARK; UNITED KINGDOM;

BACTERIA (MICROORGANISMS);

EID: 80054075776     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr201     Document Type: Article

References (17)

1. Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol. 2006; 19(3):248-254. (Pubitemid 43804678)
2. Sadovnick AD, Yee IM, Ebers GC. Multiple sclerosis and birth order: a longitudinal cohort study. Lancet Neurol. 2005;4(10): 611-617. (Pubitemid 41317295)
3. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7(3):268-277. (Pubitemid 351222732)
4. Alonso A, Jick SS, Jick H, et al. Antibiotic use and risk of multiple sclerosis. Am J Epidemiol. 2006;163(11):997-1002. (Pubitemid 43987591)
5. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399. (Pubitemid 30185417)
6. Koch-Henriksen N, Rasmussen S, Stenager E, et al. The Danish Multiple Sclerosis Registry. History, data collection and validity. Dan Med Bull. 2001;48(2):91-94.
7. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227-231. (Pubitemid 13158528)
8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol. 2005;58(6):840-846. (Pubitemid 41746873)
9. Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:111-127.
10. Dansk Lægemiddel Information. Lægemiddelkataloget 2005-2006. Copenhagen, Denmark: Dansk Lægemiddel Information 2005.
11. Weinstock MA, Colditz GA, Willett WC, et al. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133(3):240-245.
12. Siva A. The spectrum of multiple sclerosis and treatment decisions. Clin Neurol Neurosurg. 2006;108(3):333-338.
13. Leary SM, Porter B, Thompson AJ. Multiple sclerosis: diagnosis and the management of acute relapses. Postgrad Med J. 2005;81(955):302-308. (Pubitemid 40686026)
14. Lebrun C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Club Francophone de la Sclérose en Plaques. Arch Neurol. 2009;66(7):841-846.
15. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006;59(3):499-503. (Pubitemid 43358070)
16. Salvetti M, Giovannoni G, Aloisi F. Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol. 2009;22(3):201-206.
17. Gandhi R, Laroni A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2010;221(1-2):7-14.